Polikar R, Kennedy B, Ziegler M, Smith J, Nicod P
Divisions of Cardiology, University of California Medical Center, San Diego 92103.
J Clin Endocrinol Metab. 1990 Jun;70(6):1761-4. doi: 10.1210/jcem-70-6-1761.
Nine hypothyroid patients had blood pressure and pulse rate responses to the alpha-adrenergic agonist phenylephrine measured before [T4 index, 45.045 +/- 9.009 nmol/L (mean +/- SEM); TSH, 57.1 +/- 23.6 mU/L] and after 4 +/- 0.5 months of thyroid replacement therapy (T4 index, 141.570 +/- 29.601 nmol/L; TSH, 2.6 +/- 1.0 mU/L). Hypothyroid patients had a smaller blood pressure increment and heart rate decrement at both 66.7 and 100 micrograms/min infusion rates of phenylephrine. Furthermore, the slope of the dose-response curves for systolic (2.06 +/- 0.22 vs. 1.32 +/- 0.19; P less than 0.01) and diastolic (1.04 +/- 0.18 vs. 0.62 +/- 0.08; P less than 0.01) blood pressures were significantly greater after thyroid replacement therapy. Pulse rate changes remained proportional to blood pressure changes in hypothyroid patients, so there was no change in baroreflex sensitivity. Plasma norepinephrine levels were higher before than after thyroid replacement (2.41 +/- 0.28 vs. 1.82 +/- 0.29 nmol/L, respectively; P less than 0.01). Thus, hypothyroid patients have diminished pressor sensitivity to an alpha-adrenergic agonist and increased plasma levels of the alpha-adrenergic neutrotransmitter norepinephrine.
9名甲状腺功能减退患者在甲状腺替代治疗前(T4指数,45.045±9.009nmol/L(均值±标准误);促甲状腺激素,57.1±23.6mU/L)和4±0.5个月的甲状腺替代治疗后(T4指数,141.570±29.601nmol/L;促甲状腺激素,2.6±1.0mU/L)测量了对α-肾上腺素能激动剂去氧肾上腺素的血压和脉搏率反应。甲状腺功能减退患者在去氧肾上腺素输注速率为66.7和100μg/min时,血压升高幅度较小,心率下降幅度较小。此外,甲状腺替代治疗后,收缩压(2.06±0.22对1.32±0.19;P<0.01)和舒张压(1.04±0.18对0.62±0.08;P<0.01)剂量反应曲线的斜率显著更大。甲状腺功能减退患者的脉搏率变化与血压变化仍成比例,因此压力反射敏感性没有变化。甲状腺替代治疗前血浆去甲肾上腺素水平高于治疗后(分别为2.41±0.28对1.82±0.29nmol/L;P<0.01)。因此,甲状腺功能减退患者对α-肾上腺素能激动剂的升压敏感性降低,α-肾上腺素能神经递质去甲肾上腺素的血浆水平升高。